Mushroom supplement regulation is not one system. The United States treats mushroom supplements as food, not medicine, and does not pre-approve them before sale. The European Union requires many concentrated mushroom extracts and mycelium powders to pass a safety review before they can be sold at all. Several Asian markets, including Japan and China, have separate regulatory tracks for mushrooms used medicinally versus mushrooms sold as everyday food or supplements. Knowing which system applies to a product tells you a lot about how it was tested, and what its label is legally allowed to say.
Quick Answer: How the Three Systems Differ
- United States: No pre-market approval. Manufacturers are responsible for safety and truthful labeling under the Dietary Supplement Health and Education Act (DSHEA). The FDA can act after a product reaches the market if it is unsafe or mislabeled.
- European Union: Many mushroom mycelium powders and some concentrated extracts must clear a formal “novel food” safety assessment by the European Food Safety Authority (EFSA) before they can be sold, even though the traditional fruiting body of the same species may not need one.
- Asia (Japan, China, and others): Traditional Chinese Medicine and Japanese Kampo medicine have used species like reishi (lingzhi) and cordyceps for centuries. Some medicinal-grade mushroom products in China and Japan go through formal drug or health food registration, while mushrooms sold as general food ingredients follow separate, lighter rules.
How the United States Regulates Mushroom Supplements
In the US, mushroom supplements fall under the Dietary Supplement Health and Education Act of 1994 (DSHEA). This law puts the responsibility on the manufacturer, not the government, to make sure a product is safe and accurately labeled before it goes on the market. The FDA does not test or approve dietary supplements the way it approves drugs.
Instead, the FDA regulates supplements after they reach shelves. It can inspect manufacturing facilities, review labels and marketing claims, and take action against a product found to be adulterated or misbranded. Companies are prohibited from claiming a supplement diagnoses, treats, supports, or prevents a disease. They can make limited “structure/function” claims, such as describing how an ingredient supports a normal body function, but these claims must be truthful and cannot cross into medical claims.
This means two mushroom products with the same ingredient list can differ a lot in quality, because the government is not checking either one before it ships.
How the European Union Regulates Mushroom Supplements
The EU’s approach centers on a rule most American shoppers have never heard of: the Novel Food Regulation. Under this rule, any food or ingredient that was not consumed to a significant degree in the EU before May 15, 1997, is classified as a “novel food” and must pass a safety evaluation by the European Food Safety Authority before it can be legally sold.
This creates an unusual split within the same mushroom species. The fruiting body of shiitake, for example, has a long history of being eaten in Europe and is generally not considered novel. But a concentrated mycelium extract of the same mushroom, produced through modern fermentation methods that were not in common use before 1997, can be classified as novel and require separate authorization. Reishi and shiitake mycelial extracts are examples where only specific, EFSA-reviewed forms have cleared this process, while other extraction methods from the same species remain unauthorized for sale.
Cordyceps illustrates the same pattern. Traditional Cordyceps sinensis has been treated differently from cultivated Cordyceps militaris, and mycelium-based cordyceps ingredients have gone through separate novel food reviews depending on the specific strain and production method. Our guide on fruiting body versus mycelium sourcing goes deeper into why this distinction matters for supplement quality, independent of the regulatory angle.
The practical effect: a mushroom ingredient that is freely sold in the US may not be legally sellable in the EU until it passes this authorization process, or it may only be approved in specific extract forms and dosages.
How Asian Markets Regulate Medicinal Mushrooms
Several Asian countries have the longest documented history of using mushrooms like reishi (lingzhi) and cordyceps medicinally, and their regulatory systems reflect that history with dedicated tracks for medicinal use.
In Japan, Kampo medicine is the country’s system of traditional herbal formulas, and it is regulated as pharmaceutical medicine rather than as a food supplement. Japan’s Ministry of Health, Labour and Welfare maintains an official list of approved Kampo formulas, some of which are eligible for reimbursement under national health insurance. Mushroom-containing Kampo products that fall under this system go through a different approval path than a mushroom coffee or capsule sold as a general food supplement.
In China, health food products, including many mushroom-based ones, can go through the National Medical Products Administration’s “Blue Hat” (蓝帽子) registration system if they carry specific approved health function claims. This registration involves formal review by the State Administration for Market Regulation and can take years to complete. Products sold through cross-border e-commerce channels, however, often bypass Blue Hat registration and follow a separate, lighter set of import rules. Reishi, known as lingzhi in China, has additionally been studied as a component in approved pharmaceutical-grade polysaccharide products in some clinical contexts, which sits apart from the general health food category entirely. You can read more about this species in our Reishi library entry, and about cordyceps sourcing distinctions in our Cordyceps library entry.
The result across Asian markets is a patchwork: a mushroom formula positioned as medicine faces a different, often stricter, approval path than the same species sold as an everyday wellness product.
What These Differences Mean for Shoppers
None of these systems tell you whether a specific product works. What they tell you is how much independent scrutiny a product’s ingredients went through before reaching a shelf, and what the label is legally allowed to claim.
- A US label cannot legally claim a mushroom supplement treats or supports a disease, regardless of what research exists on the ingredient.
- An EU-authorized novel food ingredient has cleared a documented safety review, which is a different bar than “has a long history of traditional use.”
- An Asian medicinal-grade product with formal drug or Blue Hat registration has typically gone through more testing than the same species sold as a general food ingredient in the same country.
- Extraction method (fruiting body versus mycelium, water extract versus alcohol extract) can change a product’s regulatory status even when the species name on the label stays the same. Our supplement format guide covers how these production choices also affect what you’re actually consuming.
If a product makes strong claims about international approval, it’s worth checking which specific regulatory track it means. “Approved in Asia” is not one status, and “compliant in the US” mainly means the label followed labeling law, not that the product was pre-tested by a government agency.
Extra Caution: Pregnant, Breastfeeding, and Medicated Readers
Regulatory approval in any country is not the same as a commitment of safety for every individual. People who are pregnant or breastfeeding, people taking prescription medications, and people with liver, kidney, or autoimmune conditions should talk with a qualified healthcare provider before adding any mushroom supplement, regardless of where it was manufactured or what regulatory approvals it carries.
Frequently Asked Questions
Does FDA approval exist for mushroom supplements?
No. The FDA does not pre-approve dietary supplements, including mushroom supplements, before they go to market. Manufacturers are responsible for safety and accurate labeling, and the FDA can take action after a problem is identified.
Why is the same mushroom ingredient legal in the US but restricted in the EU?
This usually comes down to the EU’s novel food rule. If a specific extraction method, like a concentrated mycelium powder, was not commonly consumed in the EU before 1997, it may need formal safety authorization there, even if the raw mushroom itself has a long food history.
Is reishi mushroom classified as medicine anywhere?
In parts of Asia, reishi (lingzhi) has been used within traditional medicine systems for centuries, and specific reishi-derived compounds have been studied and used in formal pharmaceutical or Kampo contexts in China and Japan. In the US and most of the EU, reishi is sold and regulated as a food supplement, not a medicine.
Does a supplement’s country of manufacture tell me how strictly it was regulated?
Not by itself. What matters more is which regulatory framework the specific product was sold under, since a mushroom ingredient can be classified differently depending on its extraction method, its claimed function, and the sales channel it moves through, even within the same country.
Educational Disclaimer: This article is for general educational purposes only and summarizes public regulatory information as of the time of writing. Regulations change, and specific product statuses should be verified with the relevant regulatory body (FDA, EFSA, or the applicable national agency) before making purchasing or usage decisions. This is not legal or medical advice. Top Shelf Mushrooms is an independent editorial publication and not a medical practice, law firm, or regulatory authority. Always consult a qualified healthcare provider before starting any supplement.
None of these systems tell you whether a specific product works. What they tell you is how much independent scrutiny a product’s ingredients went through before reaching a shelf, and what the label is legally allowed to claim.
- A US label cannot legally claim a mushroom supplement treats or supports a disease, regardless of what research exists on the ingredient.
- An EU-authorized novel food ingredient has cleared a documented safety review, which is a different bar than “has a long history of traditional use.”
- An Asian medicinal-grade product with formal drug or Blue Hat registration has typically gone through more testing than the same species sold as a general food ingredient in the same country.
- Extraction method (fruiting body versus mycelium, water extract versus alcohol extract) can change a product’s regulatory status even when the species name on the label stays the same. Our supplement format guide covers how these production choices also affect what you’re actually consuming.
If a product makes strong claims about international approval, it’s worth checking which specific regulatory track it means. ”Approved in Asia” is not one status, and ”compliant in the US” mainly means the label followed labeling law, not that the product was pre-tested by a government agency.
Leave a Reply